BridgeMD
New treatment option for Memory Impairment
Official title Predictive Factors and Autonomy Level Change
ClinicalTrials.gov ID: NCT02302482
What this study is testing
- What it's testing
- The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Patients who undergo a medical visit in the Memory Clinic for the 1st time
- Patients living at home or in housing
- Patients with memory impairment, at all stage of the disease
You likely can't join if
- Patients in institution
- Patients under legal protection
- Patients with a hearing or visual impairment, which dot not allow to carry out the examination
The study team makes the final eligibility decision.
Where it's taking place
- Caluire-et-Cuire, France
- Lyon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caluire-et-Cuire, France; Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.